Bleomycin lung: a case report.

PubWeight™: 0.92‹?›

🔗 View Article (PMC 3028052)

Published in BMJ Case Rep on April 14, 2009

Authors

Rabia Sofia Rashid1

Author Affiliations

1: Medway Maritime Hospital, Windmill Road, Gillingham, Kent ME7 5NY, UK.

Articles citing this

Imatinib for bleomycin induced pulmonary toxicity: a case report and evidence-base review. Clin Case Rep (2016) 0.75

Lungs on fire. BMJ Case Rep (2013) 0.75

Articles cited by this

A clinical review of bleomycin--a new antineoplastic agent. Cancer (1973) 2.53

Bleomycins: towards better therapeutics. Nat Rev Cancer (2005) 2.52

Bleomycin-induced pneumonitis. Chest (2001) 2.13

Predicting the risk of bleomycin lung toxicity in patients with germ-cell tumours. Ann Oncol (2003) 1.49

Bleomycin pulmonary toxicity has a negative impact on the outcome of patients with Hodgkin's lymphoma. J Clin Oncol (2005) 1.46

Bleomycin-induced pulmonary toxicity. Clin Chest Med (1990) 1.44

Possible mechanisms of bleomycin-induced fibrosis. Clin Chest Med (1990) 1.36

Diagnosis and management of drug-associated interstitial lung disease. Br J Cancer (2004) 1.26

Long-term results of intratumorous bleomycin-A5 injection for head and neck lymphangioma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (1998) 1.17

Severe bleomycin lung toxicity: reversal with high dose corticosteroids. Thorax (1993) 1.08

High-resolution computed tomography of drug-induced lung disease. Clin Radiol (1992) 1.05

Factors influencing postoperative morbidity and mortality in patients treated with bleomycin. Br Med J (1978) 1.04

Bleomycin associated pulmonary toxicity: is perioperative oxygen restriction necessary? J Urol (1998) 1.00

Fatal bleomycin pulmonary toxicity in the west of Scotland 1991-95: a review of patients with germ cell tumours. Br J Cancer (1998) 0.95

Routine pulmonary function tests during bleomycin therapy. Tests may be ineffective and potentially misleading. JAMA (1980) 0.86

Potentiation of bleomycin-induced lung injury by exposure to 70% oxygen. Morphologic assessment. Am Rev Respir Dis (1982) 0.86

Bleomycin in testicular cancer: will pharmacogenomics improve treatment regimens? J Clin Oncol (2008) 0.86

Fatal bleomycin toxicity from a low cumulative dose in a patient with renal insufficiency. Cancer (1987) 0.85

Bleomycin-induced upper lobe fibrosis: a case report. Tumori (2002) 0.78